Over 1750 Total Lots Up For Auction at Five Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08

Ebit (Esaote Group) and DiA Imaging Analysis expand ultrasound AI offering on SUITESTENSA Cardiovascular PACS system

Press releases may be edited for formatting or style | October 11, 2021 Artificial Intelligence Cardiology Health IT PACS / Enterprise Imaging Ultrasound

DiA will spotlight its AI-based cardiac ultrasound analysis solutions across the upcoming British Society of Echocardiography (BSEcho) 2021 virtual event (Oct. 11-16, 2021).


About Ebit
Ebit is an Esaote Group company focused on diagnostic enterprise software for Cardiology (Cath-lab, Echocardiography, ECG, Electrophysiology and Check-ups), Cardiovascular Surgery, Radiology and Interventional Radiology. With a patient-centered approach, high-quality-services vision and cost-reduction commitment, Ebit's mission is to support healthcare professionals with streamlined digital workflows, advanced clinical applications and effective integration of all software and modalities, to enhance multi-disciplinary health services and multi-territorial data sharing, simplifying information mobility and telemedicine challenges. Ebit has been ranked by market analysts from Signify Research among the world top-ten providers in cardiology IT.


About DiA Imaging Analysis
DiA Imaging Analysis is a leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster, and accessible to all. The company's LVivo product line for cardiac and abdominal automated analysis allows clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT systems with increased speed, efficiency and accuracy. DiA serves thousands of end-users worldwide.


SOURCE DiA Imaging Analysis

Back to HCB News

You Must Be Logged In To Post A Comment